ZLD ASX · Health Care

Zelira Therapeutics Ltd

Announcements, last 12 months: 20
Price sensitive, last 12 months: 10
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
16 Oct 2026, 4:26 PM	Long Term Suspended Entities Price sensitive	AI summary
24 Aug 2026, 10:50 AM	Suspension from Official Quotation - Annual Listing Fees Price sensitive	AI summary
30 Jul 2026, 11:00 AM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
10 Jul 2026, 4:24 PM	Long Term Suspended Entities Price sensitive	AI summary
2 Jul 2026, 11:56 AM	Change of Director's Interest Notice
2 Jul 2026, 11:46 AM	Notification of cessation of securities - ZLD
1 Jul 2026, 3:00 PM	Application for quotation of securities - ZLD
15 Jun 2026, 2:11 PM	Chairman Loan
29 Apr 2026, 12:14 PM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
10 Mar 2026, 2:28 PM	Director Loan

Sign in to see all ZLD announcements.

Guidance history

30 Jul 2026

Zelira's HOPE® 1 SPV valuation post-money at US$65.96M

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow ZLD to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.